These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7856296)

  • 21. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC; Campbell H; Rahman S; Armstrong JR
    Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants.
    Berry S; Hernandez H; Kanashiro R; Campos M; Azabache V; Gomez G; Gutierrez M; Weirs B; De Quadros C; Halsey N
    Pediatr Infect Dis J; 1992 Oct; 11(10):822-7. PubMed ID: 1408479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants.
    Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY
    Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire.
    Cutts FT; Mandala K; St Louis M; Brown C; Mayala B; Zell ER; Deforest A; Kamenga M; Davachi F; Markowitz LE
    J Infect Dis; 1993 Jun; 167(6):1418-21. PubMed ID: 8501334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Child mortality after high-titre measles vaccines: prospective study in Senegal.
    Garenne M; Leroy O; Beau JP; Sene I
    Lancet; 1991 Oct; 338(8772):903-7. PubMed ID: 1681265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.
    Lepage P; Dabis F; Msellati P; Hitimana DG; Stevens AM; Mukamabano B; Van Goethem C; Van de Perre P
    Am J Dis Child; 1992 May; 146(5):550-5. PubMed ID: 1621655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.
    Samb B; Aaby P; Whittle H; Seck AM; Simondon F
    Trans R Soc Trop Med Hyg; 1993; 87(6):697-701. PubMed ID: 8296384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.
    García-León ML; Bonifaz LC; Espinosa-Torres B; Hernández-Pérez B; Cardiel-Marmolejo L; Santos-Preciado JI; Wong-Chew RM
    Hum Vaccin Immunother; 2015; 11(7):1762-9. PubMed ID: 26075901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants.
    Hussey GD; Goddard EA; Hughes J; Ryon JJ; Kerran M; Carelse E; Strebel PM; Markowitz LE; Moodie J; Barron P; Latief Z; Sayed R; Beatty D; Griffin DE
    J Infect Dis; 1996 Jun; 173(6):1320-6. PubMed ID: 8648203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.
    Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F
    Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of specific antibody and cellular immune response to first-dose measles vaccine Edmonston-Zagreb in 9-month-old infants.
    Hr TN; Barlıanto W; Wıyasa IWA; Kusuma HMSC; Sari TL; Bachtıar NS
    Allergol Immunopathol (Madr); 2021; 49(3):193-201. PubMed ID: 33938206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.